Companies that own Genmab A/S
Artisan Partners LP
3,081,731
5.01%
3,081,731
0.57%
01/09/2018
Schroder Investment Management Ltd.
2,594,661
4.22%
0
0.28%
06/30/2018
Wellington Management Co. LLP
2,114,169
3.44%
335,548
0.07%
07/31/2018
The Vanguard Group, Inc.
1,427,588
2.31%
14,599
0.01%
07/31/2018
ATP Fondsmaeglerselskab A/S
1,373,692
2.24%
-300,335
2.45%
12/31/2017
BlackRock Investment Management (UK) Ltd.
1,157,274
1.88%
16,584
0.06%
07/31/2018
OppenheimerFunds, Inc.
903,528
1.47%
18,077
0.09%
03/31/2018
Baillie Gifford & Co.
881,367
1.43%
228,765
0.1%
06/30/2018
BlackRock Fund Advisors
786,932
1.28%
4,274
0.01%
09/06/2018
Norges Bank Investment Management
769,889
1.25%
-141,111
0.02%
12/31/2017
| Address |
Kalvebod Brygge 43
Copenhagen CR 1560
Denmark
|
|
Employees
|
- |
| Website |
http://www.genmab.com |
| Updated |
07/08/2019 |
| Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer. Its antibody product, Arzerra used in the treatment of chronic lymphocytic leukemia indications; and DARZALEX. |
